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Dermatofibrosarcoma protuberans (DFSP) is a mesenchymal neoplasm of the dermis and subcutis, which can present as nodular and polypoidal mass [1]. It is a rare soft-tissue 
neoplasm originally described in 1924 by Darier and Ferrand as a 
progressive, recurrent dermatofibroma and later named DFSP by 
Hoffmann in 1925 [2]. It constitutes approximately 6% of all soft 
tissue sarcoma [3] with an estimated incidence of 0.8–0.5 cases 
per million per year [4]. DFSP occurs most frequently in the 2nd to 
4th decade of life and usually involves the trunk. Other sites involved 
are limbs, head, and neck. However, the involvement of the breast 
is rare, and to best of our knowledge, only a few case reports are 
found in the literature [5]. At least 40 case reports of DFSP in the 
breast has been reported [6]. DFSP rarely occurs in the breast, and it 
is difficult to diagnose. The differential diagnosis includes another 
mesenchymal tumor such as pseudoangiomatous stromal hyperplasia, 
myofibroblastoma, leiomyoma, and fibroepithelial malignancies 
such as phyllodes tumor and periductal stromal sarcomas [7]. 
DFSP typical storiform pattern and CD34 immunoreactivity were 
also against the diagnosis of a fibromatosis [8]. The histology of 
the tumor did not support an inflammatory myofibroblastic tumor 
because of the lack of a conspicuous inflammatory infiltrate and the 
negative smooth muscle markers and ALK1 immunoreactivity [9]. 
Both phyllodes tumor and periductal stromal hyperplasia/tumor are 
spindle cell neoplasms, but they show a biphasic pattern composed 
of spindle cells around tubular or ductal structures that were not 
present in the present tumor [8].
CASE REPORT
A 47-year-old woman presented to surgery outpatient department 
with chief complaints of lump left breast since 5 years. The lump 
was progressively increasing in size and caused mild discomfort 
to the patient. On physical examination, a 4×3 cm mobile, 
well-defined, firm, non-tender, lump was detected in the upper 
inner quadrant of the left breast. The breast sonography showed a 
4.5×3 cm slightly heteroechoic nodule located in the dermal layer, 
suggesting the possibility of a dermal lesion. Fine needle aspiration 
cytology procedure was done which suggest the cytological 
features of the mesenchymal lesion. A left-sided modified radical 
mastectomy was planned, and mastectomy specimen was send to 
the pathology department for histopathological examination.
We received a mastectomy specimen with nipple and areola 
measuring 17×15×7 cm. Cut section showed a gray-white firm 
growth measuring 4×3×3 cm involving the overlying skin 
(Fig. 1). 11 lymph nodes were identified ranging in size from 
0.5 to 1 cm. On histopathological sections examined showed a 
hypercellular tumor comprised the monotonous oval to spindle 
cells (resembling the fibroblast). These cells were arranged in 
the storiform pattern involving the entire dermis including the 
subcutis. Mitosis was rare. The overlying epidermis was thinned 
out. Deep extension from dermis into epidermis was also noted. 
No terminal ductular lobular units/mammary tissue was identified 
on the sections examined. These features suggest the possibility 
of Mesenchymal/Dermal/Fibroepithelial tumor (Fig. 2). All the 
lymph nodes showed reactive lymphoid hyperplasia.
For confirmation immunohistochemistry (IHC) was done and 
the tumor cells were strongly immunoreactive for CD34 (76–
100% of cells) which confirms the diagnosis of DFSP (Fig. 3).
DISCUSSION
DFSP is a relatively rare cutaneous malignancy that arises from 
the dermis. The reported incidence of DFSP is approximately five 
cases per one million individuals per year [10]. While it is a low-
grade sarcoma, it is capable of infiltration and local recurrence 
following inadequate excision.
ABSTRACT
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The most commonly reported sites of DFSP are the trunk and 
extremities [11]. However, it is rarely reported in the breast [12]. 
The initial presentation of DFSP is a skin lesion described as a 
single, raised, red to bluish, firm cutaneous nodule, or plaque 
with surrounding discoloration [13]. The lesion is painless and 
indurated, but is extremely infiltrative and has a locally destructive 
growth that can invade the underlying structure such as fascia, 
muscles, or bones [14].
Large core needle biopsy or excisional biopsy can help 
to provide a correct diagnosis. The characteristic findings 
are interlacing spindle-shaped tumor cells in the dermis and 
subcutaneous fat layer that forms definite bands that interweave 
or radiate like spokes of a wheel, forming a so-called “cartwheel” 
or “storiform” pattern [15]. IHC markers are highly sensitive 
for DFSP. In particular, CD34 is a useful marker that allows 
differentiation of DFSP tumor cells from normal stromal cells and 
the other mesenchymal lesions [16].
The standard treatment for localized DFSP tumor is the wide 
local surgical resection. The recommendations for complete local 
surgical resection include surgical margins of 2–3 cm and three-
dimensional resection including skin, subcutaneous tissue, and 
underlying fascia [17]. Distant metastasis is rarely observed, with 
a rate of 4–6%, predominantly to the lungs. DFSP can transform, 
especially in the recurring forms into fibrosarcomatous DFSP, a 
tumor with higher invasion and malignancy potent [18].
CONCLUSION
We highlighted a rare case of DFSP of the breast. It is a lowgrade 
sarcoma, capable of infiltration, and local recurrence. Wide local 
surgical excision remains the standard treatment for operable 
cases of DFSP. Due to high recurrence rate, long-term follow-up 
with clinical and radiological assessment is recommended for 
earlier detection of any sign of local recurrence.
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Figure 1: Gross examination of Tumor. Cut section is grey white
Figure 2: Microscopic examination showing the storiform pattern
Figure 3: IHC-CD 34 positive which confirms it is 
dermatofibrosarcoma protubrens
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